Protagonist Therapeutics Director Sells 20,000 Shares Amid Strong Stock Performance
In a recent insider transaction, Protagonist Therapeutics director William D. Waddill exercised stock options and sold 20,000 shares of PTGX…
In a recent insider transaction, Protagonist Therapeutics director William D. Waddill exercised stock options and sold 20,000 shares of PTGX…
The global confectionery market, valued at USD 227.58 billion in 2026, is on track to surpass USD 299.18 billion by…
Maison Battat has launched the 2026 Keepsake Collection for Our Generation, a full-year series of limited-edition seasonal 18-inch dolls exclusively…
United Airlines Holdings has demonstrated robust recovery and profitability in recent years, posting record revenues of $59.1 billion in 2025…
“Tom Lee, the prominent market strategist and chairman of BitMine Immersion, has boldly declared that Jimmy Donaldson, better known as…
“Tonight at 6:30 PM EST, Bloomberg Television features New to The Street Show #726, showcasing Vivos Therapeutics (NASDAQ:VVOS) advancing non-surgical…
“U.S. stocks extended losses following a sharp tech-led decline on Wall Street, with major indices closing lower amid renewed concerns…
“Dubai’s state-owned DP World has swiftly replaced its longtime chairman and CEO, Sultan Ahmed bin Sulayem, following intense scrutiny over…
Adyen has strengthened its long-standing partnerships with Uber and accesso Technology Group, expanding payment integrations to support global scale, new…
“Recent Form 8.5 (EPT/RI) disclosures from exempt principal traders like Investec Bank plc and Peel Hunt LLP reveal ongoing client-serving…